Other
Endothelial Function
0
Pipeline Programs↗
6
Active Trials↗
5
Companies Involved↗
Endothelial Function is an early-stage landscape with 0 programs across 5 companies. The most active players are Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Sanofi, Korea Otsuka Pharmaceutical Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
113
clinical trials
Completed75 · 66%
Unknown status18 · 16%
Terminated8 · 7%
Withdrawn6 · 5%
Recruiting3 · 3%
Active, not recruiting2 · 2%
Other1 · 1%
Clinical Trials
Trial Activity
113 trials
Role of Endothelial Function in SCI CVD Risk
Recruiting·—·N/A·NCT06443151·60 enrolled
Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery
Active, not recruiting·—·N/A·NCT03636243·37 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)